Clinical Trials Directory

Trials / Completed

CompletedNCT03933644

Ambu Aura GainTM Guided vs Non Guided in Edentulous Ambu Aura GainTM Without Gastric Tube in Endontolous Patient

Comparison of the Ambu Aura GainTM With Gastric Tube Versus the Ambu Aura GainTM Without Gastric Tube in Endontolous Patient

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Medical University Innsbruck · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The Ambu® Aura GainTM is a relatively new 2nd generation Supraglottic Airway Device (SGA) with a second port, providing gastric access to drain gastric content and air and it has an intergrated bite-block that helps avoiding rotation of the SGA. It has been described and it is known from daily routine, that SGA in edentulous patient provide inferior oropharyngeal leak pressure (OLP). The aim of the study is to evaluate if the placement of a gastric tube through the second orifice leads to better OLP and lowers the number of intervention needed for replacing the SGA. The study also evaluates the OLP after 15 minutes and after 30 minutes.

Conditions

Interventions

TypeNameDescription
DEVICEGastric TubeSGA is inserted with a gastric tube as guide for insertion
DEVICENo gastric TubeSGA is inserted without a gastric tube as guide for insertion

Timeline

Start date
2019-05-15
Primary completion
2020-02-12
Completion
2020-02-12
First posted
2019-05-01
Last updated
2020-11-23

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03933644. Inclusion in this directory is not an endorsement.